Michael Amoroso's most recent trade in Abeona Therapeutics Inc was a trade of 36,101 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 180,466 (0%) | 0% | 0 | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 115,388 | 143,925 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 69,421 | 138,842 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 37,079 | 74,138 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 20 Jan 2025 | 36,838 | 107,087 (0%) | 0% | 4.7 | 172,033 | Common Stock |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 8,888 | 8,888 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 9,443 | 9,444 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 9,443 | 31,549 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.19 per share. | 02 Nov 2024 | 3,012 | 28,537 (0%) | 0% | 8.2 | 24,668 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 144,365 (0%) | 0% | 0 | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 208,263 | 208,263 | - | - | Restricted Stock Units | |
Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 132,568 (0%) | 0% | 0 | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 08 May 2024 | 8,334 | 22,106 (0%) | 0% | 12 | 100,008 | Common Stock |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,417 | 3,417 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,417 | 15,298 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 01 May 2024 | 1,526 | 13,772 (0%) | 0% | 10.3 | 15,748 | Common Stock |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 111,217 | 111,217 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Amoroso Michael | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 266,720 | 493,823 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 266,720 | 533,280 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 20 Jan 2024 | 137,390 | 356,433 (0%) | 0% | 0.4 | 49,460 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 20 Jun 2023 | 338 | 114,792 (0%) | 0% | 4.4 | 1,504 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 115,130 (0%) | 0% | 4.6 | 271,143 | Common Stock |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 102,535 | 115,737 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 102,535 | 205,009 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 21 Mar 2023 | 46,999 | 68,738 (0%) | 0% | 0.8 | 38,539 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 20 Mar 2023 | 268 | 56,441 (0%) | 0% | 2.3 | 624 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 03 Mar 2023 | 1,002 | 56,709 (0%) | 0% | 2.4 | 2,385 | Common Stock |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 800,000 | 800,000 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 850,000 | 850,000 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 24,208 | 0 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 24,208 | 24,208 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 15 Oct 2022 | 11,006 | 13,202 (0%) | 0% | 1.3 | 14,528 | Common Stock |
Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 57,711 (0%) | 0% | 0 | Common Stock | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 482,771 | 482,771 | - | - | Employee Stock Option (Right to Buy) | |
Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 307,544 | 307,544 | - | - | Restricted Stock Units | |
Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 30 Sep 2021 | 45,409 | 604,637 (0%) | 0% | 1.1 | 49,382 | Common stock |
Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.87 per share. | 31 Mar 2021 | 45,409 | 650,046 (0%) | 0% | 1.9 | 84,919 | Common stock |
Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 250,000 | 695,455 (0%) | 0% | 0 | Common stock | |
Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 200,000 | 445,455 (0%) | 0% | 0 | Common stock | |
Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 250,000 | 0 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |